Compare ON & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ON | GEHC |
|---|---|---|
| Founded | 1992 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Computer Software: Prepackaged Software |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 32.1B |
| IPO Year | 2000 | 2022 |
| Metric | ON | GEHC |
|---|---|---|
| Price | $85.21 | $74.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 13 |
| Target Price | $65.29 | ★ $89.23 |
| AVG Volume (30 Days) | ★ 7.6M | 3.0M |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.19% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | 0.29 | ★ 4.55 |
| Revenue | $5,878,300,000.00 | ★ $20,625,000,000.00 |
| Revenue This Year | $7.93 | $7.12 |
| Revenue Next Year | $8.90 | $4.45 |
| P/E Ratio | $286.72 | ★ $16.40 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $37.19 | $60.83 |
| 52 Week High | $83.52 | $89.77 |
| Indicator | ON | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 82.47 | 52.56 |
| Support Level | $53.64 | $69.59 |
| Resistance Level | N/A | $74.83 |
| Average True Range (ATR) | 2.78 | 1.67 |
| MACD | 2.32 | 0.61 |
| Stochastic Oscillator | 99.44 | 74.34 |
Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and the largest supplier of image sensors to the automotive market. While the firm used to be highly vertically integrated, it now pursues a hybrid manufacturing strategy for flexible capacity. Onsemi is pivoting to focus on emerging applications like electric vehicles, autonomous vehicles, industrial automation, and renewable energy.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).